Cargando…

Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer’s drugs

Detalles Bibliográficos
Autor principal:	Piemontese, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358667/ https://www.ncbi.nlm.nih.gov/pubmed/37449616 http://dx.doi.org/10.4103/1673-5374.373685

Ejemplares similares

New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge
por: Piemontese, Luca
Publicado: (2017)

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
por: Brunetti, Leonardo, et al.
Publicado: (2019)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

The Multifaceted Opportunities Provided by the Pheomelanin-Inspired 1,4-Benzothiazine Chromophore: A Still-Undervalued Issue
por: Alfieri, Maria Laura, et al.
Publicado: (2023)

Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
por: Syal, Charvi, et al.
Publicado: (2021)

Biomass carbon mining to develop nature-inspired materials for a circular economy
por: Bachs-Herrera, Anna, et al.
Publicado: (2023)

Future directions for medicinal chemistry in the field of oligonucleotide therapeutics
por: Hall, Jonathan
Publicado: (2023)

Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders
por: Lui, Austin, et al.
Publicado: (2022)

Challenges and opportunities for modeling coupled human and natural systems
por: Li, Yan, et al.
Publicado: (2023)

Brain network modulation in Alzheimer’s disease: clinical phenotypes and windows of opportunity
por: Pini, Lorenzo
Publicado: (2022)

A Historical Misconception in Clinical Trials of Drugs for Cancer—Age Grouping
por: Chen, Jingyu, et al.
Publicado: (2022)

The great opportunity: Evolutionary applications to medicine and public health
por: Nesse, Randolph M, et al.
Publicado: (2008)

Barriers and Opportunities for Use of Patient Registries in Medicines Regulation
por: Olmo, Carla Alonso, et al.
Publicado: (2019)

Sex, ApoE4 and Alzheimer’s disease: rethinking drug discovery in the era of precision medicine
por: Paranjpe, Manish D., et al.
Publicado: (2021)

Multinational enterprises and natural disasters: Challenges and opportunities for IB research
por: Oh, Chang Hoon, et al.
Publicado: (2022)

Reverse Pharmacology Applicable for Botanical Drug Development – Inspiration from the Legacy of Traditional Wisdom
por: Surh, Young-Joon
Publicado: (2011)

A Mini Review on Natural Safeners: Chemistry, Uses, Modes of Action, and Limitations
por: Deng, Xile
Publicado: (2022)

Challenges and Opportunities in Academic Hospital Medicine: Report from the Academic Hospital Medicine Summit
por: Flanders, Scott A., et al.
Publicado: (2009)

Can foods influence the onset and progress of neurodegenerative diseases?
por: Piemontese, Luca, et al.
Publicado: (2022)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

Neurorestoration from medicinal plants: an opportunity to treat painful neuropathies
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2017)

Precision medicine for acute pancreatitis: current status and future opportunities
por: Mukherjee, Rajarshi, et al.
Publicado: (2019)

Entering the ‘big data’ era in medicinal chemistry: molecular promiscuity analysis revisited
por: Hu, Ye, et al.
Publicado: (2017)

Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer’s Disease
por: Piemontese, Luca, et al.
Publicado: (2018)

Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Converging multi-modality datasets to build efficient drug repositioning pipelines against Alzheimer’s disease and related dementias
por: Yin, Zheng, et al.
Publicado: (2022)

Multi-faceted small molecule for Alzheimer’s disease
por: Park, Min Hee, et al.
Publicado: (2023)

Opportunities and Challenges of Using Big Data to Detect Drug‐Drug Interaction Risk
por: Quinney, Sara K.
Publicado: (2019)

Historical Scientific Racism and Psychiatric Publications: A Necessary International Anti-racist Code of Ethics
por: Ben-Cheikh, Imen, et al.
Publicado: (2021)

High altitude medicine in China in the 21st century: opportunities and challenges
por: Huang, Lan
Publicado: (2014)

Opportunities for traditional Chinese medicine to address unmet challenges in modern healthcare
por: Cheng, Yung-Chi
Publicado: (2015)

Applying Game Theory Models to Inpatient Medicine: Opportunities to Improve Care
por: Yeung, Ho-Man, et al.
Publicado: (2023)

Systems Approaches: A Global and Historical Perspective on Integrative Medicine
por: Hanaway, Patrick
Publicado: (2012)

Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research
por: Britton, Gabrielle B., et al.
Publicado: (2023)

Bio-inspired adhesion control with liquids
por: Chen, Yupeng, et al.
Publicado: (2022)

Model Informed Drug Development and Regulation in China: Challenges and Opportunities
por: Li, Li, et al.
Publicado: (2019)

Challenges and opportunities for improving access to approved neonatal drugs and devices
por: Lewis, Tamorah, et al.
Publicado: (2022)

Medicinal Chemistry of Novel Anti-Diabetic Drugs
por: Adeghate, Ernest
Publicado: (2011)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
por: Osborne, Olivia M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2kpdacj6cgg482pulidpau6a67